https://stock.noler.com/us/stock/intellipharmaceutics-international-inc https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-payable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-receivable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-receivable-gross https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accounts-receivable-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accretion-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accrual-for-taxes-other-than-income-taxes-current-and-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accrued-liabilities-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accumulated-depreciation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/accumulated-depreciation-change https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/additional-paid-in-capital https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/aoci https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/asset-impairment-charges https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/asset-reporting-currency-denominated-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/assets-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/basic-shares https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-expenditures https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-lease-obligations https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-and-equivalents https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cash-flow-breakdown https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/common-stock-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/comprehensive-income https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/convertible-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/convertible-debt-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/convertible-notes-payable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cost-of-goods-and-services-sold-depreciation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cost-of-goods-sold https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cost-of-revenue https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/costs-and-expenses https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/cumulative-earnings-deficit https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/current-assets https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/current-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-convertible-carrying-amount-of-the-equity-component https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-convertible-number-of-equity-instruments https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-face-amount https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-interest-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-offering-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-revenue https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-revenue-2 https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-revenue-additions https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-tax-credit-carryforwards-foreign https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-tax-credit-carryforwards-general-business https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-liabilities-gross-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/deferred-tax-liabilities-unrealized-currency-transaction-gains https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/depreciation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/depreciation-and-amortization https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/derivative-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/diluted-shares https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/direct-operating-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/due-from-banks https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/due-to-related-parties-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/effect-on-future-cash-flows-amount https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/eps https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/eps-basic https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/fair-value-net-asset-liability https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-cash-flow https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-interest-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-receivable-recorded-investment-30-to-59-days-past-due https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-receivable-recorded-investment-60-to-89-days-past-due https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-receivable-recorded-investment-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/financing-receivable-recorded-investment-past-due https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/form-d-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/geographic-revenue-from-external-customers-attributed-to-foreign-countries https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/gross-profit https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/guarantee-obligations-maximum-exposure https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-loss-from https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-tax https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-taxes-paid https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-income-taxes-payable-net-of-income-taxes-receivable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-expense-on-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-expense-related-party https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-income-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-paid https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/interest-paid-net https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/inventory https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/inventory-finished-goods https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/inventory-raw-materials https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/inventory-work-in-process https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/inventory-write-down https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/investing-cash-flow https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/investment-income-interest https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/investment-tax-credit https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/lease-cost https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/level-3-liability-issues https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/level-3-liability-settlements https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/liability-reporting-currency-denominated-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/licenses-revenue https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/litigation-settlement-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-change-in-cash https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-income https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/noninterest-bearing-deposit-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/noninterest-expense-offering-cost https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/noninterest-income-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/notes-payable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/notes-payable-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/oci-before-tax https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/oci-net-of-tax https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-cash-flow https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-expenses https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-income https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-assets https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-liability https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-liability-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-additional-capital https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-current-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-income https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-noncash-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-receivables https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/other-receivables-gross-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-shares-issued-ownshare-lending-arrangement-issuance-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-for-fees https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-for-reinsurance https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-of-capital-distribution https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-of-financing-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/preferred-shares-facts https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/pretax-income https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-sale-of-other-property-plant-and-equipment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/profit-loss https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/property-plant-and-equipment-additions https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/property-plant-equipment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/public-float https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/real-estate-federal-income-tax-basis https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/receivables-net-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/registration-payment-arrangement-maximum-potential-consideration https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/repayments-of-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/research-and-development https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/research-and-development-arrangement-contract-to-perform-for-others-compensation-earned https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/retained-earnings https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/revenue https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/sales-revenue-services-gross https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/sga-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/shareholders-equity https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/shares-held-in-employee-stock-option-plan-allocated https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/shares-issued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/shares-repurchased https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/shares-repurchased-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-non-option-equity-instruments-expirations https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-based-compensation https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-granted-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-forfeitures-and-expirations-in-period-weighted-average-intrinsic-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-tax-credits-investment https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-tax-credits-other https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/taxes-payable-current https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/total-assets https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/total-liabilities https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/unsecured-debt https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/utb-income-tax-penalties-expense https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/intellipharmaceutics-international-inc/weighted-average-number-of-share-outstanding-basic-and-diluted